- Record: found
- Abstract: found
- Article: not found
Telaprevir for retreatment of HCV infection.
Stefan Zeuzem
1 ,
Pietro Andreone ,
Stanislas Pol ,
Eric Lawitz ,
Moises Diago ,
Stuart Roberts ,
Roberto Focaccia ,
Zobair Younossi ,
Graham R Foster ,
Andrzej Horban ,
Peter Ferenci ,
Frederik Nevens ,
Beat Müllhaupt ,
Paul Pockros ,
Ruben Terg ,
Daniel Shouval ,
Bart van Hoek ,
Ola Weiland ,
Rolf Van Heeswijk ,
Sandra De Meyer ,
Don Luo ,
Griet Boogaerts ,
Ramon Polo ,
Gaston Picchio ,
Maria Beumont
Jun 23 2011
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Up to 60% of patients with hepatitis C virus (HCV) genotype 1 infection do not have a sustained virologic response to therapy with peginterferon alfa plus ribavirin.